Paulson & Co. Inc.
- SEC CIK
- 0001035674
- Latest filing
- Aug 14, 2026
PCRX holding history
Pacira BioSciences, Inc. in every 13F filed by Paulson & Co. Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PCRX overviewAll 13F holders of PCRXFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −350,000−100.0% | Sold out | Holders |
| Q2 2022 | 350,000 | $20.4M | 1.0% | −150,000−30.0% | Reduced | Holders |
| Q1 2022 | 500,000 | $38.2M | 1.2% | −1,205,599−70.7% | Reduced | Holders |
| Q4 2021 | 1,705,599 | $102.6M | 3.2% | +446,081+35.4% | Added | Holders |
| Q3 2021 | 1,259,518 | $70.5M | 2.0% | −13,643−1.1% | Reduced | Holders |
| Q2 2021 | 1,273,161 | $77.3M | 1.8% | −140,693−10.0% | Reduced | Holders |
| Q1 2021 | 1,413,854 | $99.1M | 2.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.